J.W.M. Lenders, Q.Y. Duh, G. Eisenhofer, A.P. Gimenez-Roqueplo, S.K.G. Grebe, M.H. Murad, M. Naruse, K. Pacak, W.F. Young, Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99, 1915–1942 (2014). https://doi.org/10.1210/jc.2014-1498

Article  CAS  PubMed  Google Scholar 

S. Nölting, N. Bechmann, D. Taieb, F. Beuschlein, M. Fassnacht, M. Kroiss, G. Eisenhofer, A. Grossman, K. Pacak, Personalized Management of Pheochromocytoma and Paraganglioma. Endocr Rev 43, 199–239 (2022). https://doi.org/10.1210/endrev/bnab019

Article  PubMed  Google Scholar 

A.R. Al Subhi, V. Boyle, M.S. Elston, Systematic review: incidence of pheochromocytoma and paraganglioma over 70 years. J Endocr Soc. 6, (2022). https://doi.org/10.1210/jendso/bvac105

P.T.K. Gunawardane, A. Grossman, Phaeochromocytoma and paraganglioma. Adv Exp Med Biol 956, 239–259 (2016). https://doi.org/10.1007/5584_2016_76

Article  Google Scholar 

E. Barth, G. Albuszies, K. Baumgart, M. Matejovic, U. Wachter, J. Vogt, P. Radermacher, E. Calzia, Glucose metabolism and catecholamines. Crit Care Med 35, S508–S518 (2007). https://doi.org/10.1097/01.CCM.0000278047.06965.20

Article  CAS  PubMed  Google Scholar 

K.J. Ioakim, G.I. Sydney, S.A. Paschou, Glucose metabolism disorders in patients with adrenal gland disorders: pathophysiology and management. Hormones 19, 135–143 (2020). https://doi.org/10.1007/s42000-019-00147-z

Article  PubMed  Google Scholar 

A. Elenkova, J. Matrozova, V. Vasilev, R. Robeva, S. Zacharieva, Prevalence and progression of carbohydrate disorders in patients with pheochromocytoma/paraganglioma: retrospective single-center study. Ann Endocrinol 81, 3–10 (2020). https://doi.org/10.1016/j.ando.2020.01.001

Article  Google Scholar 

S. Derrou, T. Bouziane, H. Salhi, H. El Ouahabi, Pheochromocytoma and glucoregulation disorders. Ann Afr Med 20, 42–45 (2021). https://doi.org/10.4103/aam.aam_13_20

Article  PubMed  PubMed Central  Google Scholar 

T. Beninato, W.P. Kluijfhout, F.T. Drake, J. Lim, J.S. Kwon, M. Xiong, W.T. Shen, J.E. Gosnell, C. Liu, I. Suh, Q.Y. Duh, Resection of pheochromocytoma improves diabetes mellitus in the majority of patients. Ann Surg Oncol 24, 1208–1213 (2017). https://doi.org/10.1245/s10434-016-5701-6

Article  PubMed  Google Scholar 

S. Khatiwada, S. Agarwal, D. Kandasamy, V.P. Jyotsna, R. Kumar, V. Kumar Bansal, R.M. Pandey, N. Gupta, N. Tandon, Diabetes mellitus in pheochromocytoma and paraganglioma: prevalence, dynamics of insulin secretion/sensitivity and predictors of remission. Diabetes Metab Syndr Clin Res Rev. 14, 2169–2175 (2020). https://doi.org/10.1016/j.dsx.2020.10.030

Article  Google Scholar 

Z.H. Liu, L. Zhou, L. Lin, De, T. Chen, Q.Y. Jiang, Z.H. Liu, K.J. Wang, Y.C. Zhu, H. Li, Y. Ren, Will the resection of pheochromocytoma improve preoperative diabetes mellitus. Asian J Surg 42, 990–994 (2019). https://doi.org/10.1016/j.asjsur.2019.01.012

Article  PubMed  Google Scholar 

D.C.D. Hope, J.M. Palan Unusual presentation of phaeochromocytoma. BMJ Case Rep (2016). https://doi.org/10.1136/bcr-2016

S. Douma, K. Petidis, N. Kartali, K. Mahera, C. Sabanis, C. Zamboulis, Pheochromocytoma presenting as diabetic ketoacidosis. J Diabetes Complicat. 22, 295–296 (2008). https://doi.org/10.1016/j.jdiacomp.2007.02.006

Article  Google Scholar 

C. Ishii, K. Lnoue, K. Negishi, N. Tane, T. Awata, S. Katayama, Diabetic ketoacidosis in a case of pheochromocytoma. Diabetes Res Clin Pract 54, 137–142 (2001)

Article  CAS  PubMed  Google Scholar 

I.S. Lee, T.W. Lee, C.J. Chang, Y.M. Chien, T.I. Lee, Pheochromocytoma presenting as hyperglycemic hyperosmolar syndrome and unusual fever. Intern Emerg Med 10, 753–755 (2015). https://doi.org/10.1007/s11739-015-1217-5

Article  PubMed  Google Scholar 

C. Kii, E.R. Edelman, C.A. Stuenkel, J.D. Rutherford, G.H. Williams, Diabetic ketoacidosis associated with pheochromocytoma. Cleve Clin J Med 59, 423–427 (1992)

Article  Google Scholar 

H. Hirai, S. Midorikawa, S. Suzuki, H. Sasano, T. Watanabe, H. Satoh, Somatostatin-secreting pheochromocytoma mimicking insulin-dependent diabetes mellitus. Intern Med 55, 2985–2991 (2016). https://doi.org/10.2169/internalmedicine.55.7071

Article  PubMed  PubMed Central  Google Scholar 

B.P. Wang, L.L. Yang, H. Wang, Q. He, Z.S. Ma, Y. Lin, C.X. Jiang, H.R. Sun, M. Liu, An unusual case of ectopic corticotrophin-releasing hormone syndrome caused by an adrenal noncatecholamine-secreting pheochromocytoma: a case report. BMC Endocr Disord 18, (2018). https://doi.org/10.1186/s12902-018-0269-8

S. Zaman, B. Patel, P. Glynne, M. Vanderpump, A. Alsafi, S. Khan, R. Flora, F. Palazzo, F. Wernig, A rare cause of severe Cushing’s syndrome. Endocrinol Diabetes Metab Case Rep 2020, (2020). https://doi.org/10.1530/EDM-20-0011

S.F.W.M. Hatta, L. Lekkakou, A. Viswananth, H. Buch, Ectopic adrenocorticotrophic hormone syndrome (EAS) with phaeochromocytoma: a challenging endocrine case with a happy ending. BMJ Case Rep 12, (2019). https://doi.org/10.1136/bcr-2019-230636

E. Diamanti-Kandarakis, E. Zapanti, M.-H. Peridis, P. Ntavos, G. Mastorakos, Insulin resistance in pheochromocytoma improves more by surgical rather than by medical treatment. Hormones. 2, 61–66 (2003)

Article  PubMed  Google Scholar 

N. Morita, T. Hosaka, Y. Yamazaki, K. Takahashi, H. Sasano, H. Ishida, Abnormal glucose tolerance in a patient with pheochromocytoma and ACTH-independent subclinical Cushing’s syndrome involving the same adrenal gland. J Int Med Res 47, 3360–3370 (2019). https://doi.org/10.1177/0300060519855179

Article  CAS  PubMed  PubMed Central  Google Scholar 

I. Abe, H. Fujii, H. Ohishi, K. Sugimoto, M. Minezaki, M. Nakagawa, S. Takahara, T. Kudo, M. Abe, K. Ohe, T. Yanase, K. Kobayashi, Differences in the actions of adrenaline and noradrenaline with regard to glucose intolerance in patients with pheochromocytoma. Endocr J 66, 187–192 (2019)

Article  CAS  PubMed  Google Scholar 

O. Petrák, D. Haluzíková, J. Klímová, M. Zítek, R. Holaj, D. Michalský, K. Novák, R. Petráková-Doležalová, J. Kvasnička, T.M.P.N. Nguyen, Z. Krátká, M. Matoulek, J. Widimský, T. Zelinka, Hypermetabolism and substrate utilization rates in pheochromocytoma and functional paraganglioma. Biomedicines. 10, (2022). https://doi.org/10.3390/biomedicines10081980

T.D. Wiesner, M. Blüher, M. Windgassen, R. Paschke, Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma. J Clin Endocrinol Metab 88, 3632–3636 (2003). https://doi.org/10.1210/jc.2003-030000

Article  CAS  PubMed  Google Scholar 

I. Abe, F. Islam, A.K.Y. Lam, Glucose intolerance on phaeochromocytoma and paraganglioma—the current understanding and clinical perspectives. Front Endocrinol. 11, (2020). https://doi.org/10.3389/fendo.2020.593780

D.C. Deibert, R.A. Defronzo, Epinephrine-induced insulin resistance in man. J Clin Invest 65, 717–721 (1980)

Article  CAS  PubMed  PubMed Central  Google Scholar 

R.A. Rizza, P.E. Cryer, M.W. Haymond, J.E. Gerich, Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest 65, 682–689 (1980)

Article  CAS  PubMed  PubMed Central  Google Scholar 

M. Murabayashi, M. Daimon, H. Murakami, T. Fujita, E. Sato, J. Tanabe, Y. Matsuhashi, S. Takayasu, M. Yanagimachi, K. Terui, K. Kageyama, I. Tokuda, K. Sawada, K. Ihara. Association between higher urinary normetanephrine and insulin resistance in a Japanese population. PLoS One. 15, (2020). https://doi.org/10.1371/journal.pone.0228787

A. Bonen, L.A. Megeney, S.C. Mccarthy, J.C. Mcdermottt, M.H. Tan, Epinephrine administration stimulates GLUT4 translocation but reduces glucose transport in muscle. Biochem Biophys Res Commun 187, 685–691 (1992)

Article  CAS  PubMed  Google Scholar 

S. Mukaida, M. Sato, A.I. Öberg, N. Dehvari, J.M. Olsen, M. Kocan, M.L. Halls, J. Merlin, A.L. Sandström, R.I. Csikasz, B.A. Evans, R.J. Summers, D.S. Hutchinson, T. Bengtsson, BRL37344 stimulates GLUT4 translocation and glucose uptake in skeletal muscle via β2-adrenoceptors without causing classical receptor desensitization. Am J Physiol Regul Integr Comp Physiol 316, R666–R677 (2019). https://doi.org/10.1152/ajpregu.00285.2018

Article  CAS  PubMed  Google Scholar 

X.-X. Han, A. Bonen, Epinephrine translocates GLUT-4 but inhibits insulin-stimulated glucose transport in rat muscle. Am J Physiol Endocrinol Metab 274, E700–E707 (1998)

Article  CAS  Google Scholar 

I. Raz, A. Katz, M.K. Spencer, Epinephrine inhibits insulin-mediated glycogenesis but enhances glycolysis in human skeletal muscle. Am J Physiol 260, E430–E435 (1991)

CAS  PubMed  Google Scholar 

M. Niklasson, A. Holmäng, P. Lönnroth, Induction of rat muscle insulin resistance by epinephrine is accompanied by increased interstitial glucose and lactate concentrations. Diabetologia. 41, 1467–1473 (1998)

Article  CAS  PubMed  Google Scholar 

T. Shi, R.S. Papay, D.M. Perez, The role of α1-adrenergic receptors in regulating metabolism: increased glucose tolerance, leptin secretion and lipid oxidation. J Recept Signal Transduct Res 37, 124–132 (2017). https://doi.org/10.1080/10799893.2016.1193522

Article  CAS  PubMed  Google Scholar 

J. Akinaga, J.A. Garcíasáinz, A.S. Pupo, Updates in the function and regulation of α1 -adrenoceptors. Br J Pharmacol 176, 2343–2357 (2019). https://doi.org/10.1111/bph.v176.14/issuetoc

Article  CAS  PubMed  PubMed Central  Google Scholar 

V. Goral, Y. Jin, H. Sun, A.M. Ferrie, Q. Wu, Y. Fang, Agonist-directed desensitization of the β2-adrenergic receptor. PLoS One 6, e1982 (2011). https://doi.org/10.1371/journal.pone.0019282

Article  CAS  Google Scholar 

J.A. Ronen, M. Gavin, M.D. Ruppert, A.N. Peiris, Glycemic disturbances in pheochromocytoma and paraganglioma. Cureus 11, e4551 (2019). https://doi.org/10.7759/cureus.4551

Article  PubMed  PubMed Central  Google Scholar 

A.G. Bearn, B. Billing, S. Sherlock, The effect of adrenaline and noradrenaline on hepatic blood flow and splanchnic carbohydrate metabolism in man. J Physiol 15, 430–474 (1951)

Article  Google Scholar 

M. Tomoyasu, Y. Mori, A. Fukase, H. Kushima, T. Hirano Pheochromocytoma presenting with severe hyperglycemia and metabolic acidosis following intra-articular glucocorticoid administration: a case report. J Med Case Rep. 13, (2019), https://doi.org/10.1186/s13256-018-1945-z

G.R. Mullins, L. Wang, V. Raje, S.G. Sherwood, R.C. Grande, S. Boroda, J.M. Eaton, S. Blancquaert, P.P. Roger, N. Leitinger, T.E. Harris, Catecholamine-induced lipolysis causes mTOR complex dissociation and inhibits glucose uptake in adipocytes. Proc Natl Acad Sci USA 111, 17450–17455 (2014). https://doi.org/10.1073/pnas.1410530111

Article  CAS  PubMed  PubMed Central  Google Scholar